OTC Medicines

Select an Issue

Browse OTC Medicines Content

Black teenager on their smartphone

Press Releases and Statements

House Subcommittee Marks Up Legislation to Prevent Teen Over-the-Counter Cough Medicine Abuse

CHPA, which represents leading manufacturers of OTC cough medicines, strongly supports this legislation and is joined many by substance abuse prevention organizations such as the Community Anti-Drug Coalitions of America and the Partnership for Drug-Free Kids.

Apr 20, 2016

Young brown haired child brushing teeth

Submission

Comments to NTP: Fluoride

These comments are submitted on behalf of CHPA in response to the National Institutes of Health notice entitled, “Nominations to the Report on Carcinogens and Office of Health Assessment and Translation; Request for Information”.

Apr 18, 2016

FDA headquarters sign in Washington DC

Press Releases and Statements

CHPA Speaks During FDA Meeting for Differin® Gel Switch Application

CHPA spoke today before a Food and Drug Administration Advisory Nonprescription Drugs Advisory Committee, during which the committee discussed data submitted by Galderma Laboratories, L.P. to support the supplemental new drug application for over-the-counter marketing of adapalene gel 0.1%.

Apr 15, 2016

florida capitol building with trees and clouds

Press Releases and Statements

CHPA Applauds Florida Lawmakers for Age-18 Sales Law on Cough Medicine

CHPA released the following statement today in support of a Florida law prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan (DXM) to minors.

Apr 1, 2016

Orange CHPA logo on dark blue background

Submission

Comments to FDA: Fixed-Combination and Co-Packaged Drugs

In general, CHPA supports FDA's intent to harmonize the requirements for Rx and OTC products and make them consistent with long-standing Agency policy.

Mar 22, 2016

Colleagues Examining Data on a computer

Submission

Comments to FDA: OTC Sunscreens Safety and Effectiveness Data

Comments regarding guidance for industry pertaining to sunscreen ingredients requesting inclusion into the OTC sunscreen monograph.

Feb 22, 2016

Biking into the Sunset

Submission

Comments to FDA: Sunscreen Innovation Act

Enclosed herein are comments on "Guidance for Industry; Sunscreen Innovation Act: Section 586C(c) Advisory Committee Process."

Jan 19, 2016

Orange CHPA logo on dark blue background

Submission

Comments to FDA: SIA, Withdrawal of a 586A Request or Pending Request

Enclosed herein are comments on "Guidance for Industry; Sunscreen Innovation Act: Withdrawal of a 586A Request or Pending Request", published as Draft Guidance.

Jan 19, 2016

Colleagues Examining Data on a computer

Submission

Comments to FDA: Sunscreen Drug Products - Content and Format of Data Submissions

Enclosed herein are comments on "Guidance for Industry; Nonprescription Sunscreen Drug Products - Content and Format of Data Submissions to Support a GRASE determination Under the Sunscreen Innovation Act."

Jan 19, 2016

Female Scientist wearing goggles

Submission

EPA Proposed Management Standards for Hazardous Waste Pharmaceuticals

CHPA supports EPA's efforts to streamline regulations under RCRA. CHPA has two central comments on the proposal.

Dec 23, 2015

Filter Results